trimethoprim has been researched along with Cancer of Pelvis in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessell, EM | 1 |
| Granville-White, M | 1 |
1 other study available for trimethoprim and Cancer of Pelvis
| Article | Year |
|---|---|
The effect of prophylactic trimethoprim on aerobic urinary tract infection during pelvic radiotherapy and the incidence of infections due to fastidious or anaerobic organisms.
Topics: Adult; Aged; Aged, 80 and over; Bacteria, Anaerobic; Bacterial Infections; Female; Humans; Male; Mid | 1994 |